trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Rheumatoid arthritis is associated with lower bone mineral density and a higher risk of osteoporosis.

the verdict
INSUFFICIENT LEANING
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that rheumatoid arthritis is associated with lower bone mineral density and a higher risk of osteoporosis?

Unclear. Several peer-reviewed items and reference works state or assume that rheumatoid arthritis is linked to lower bone mineral density and higher osteoporosis risk, including a cohort finding lower hip BMD with erosions and a clinic cohort reporting 65.8% low BMD among RA patients. However, these are single-cohort or background statements rather than a general quantitative demonstration of the association.

Verdict: PARTIAL LEAN · 7 sources for, 0 against · Last checked

The private library was unavailable for some searches in this check. Missing library results are not evidence against the claim.

Evidence for · 7
Rheumatoid arthritis
Get citation
Rheumatoid arthritis. (n.d.). en.wikipedia.org. https://en.wikipedia.org/wiki/Rheumatoid_arthritis

See more details
More for · 6
A Clinical Evaluation of the Role of Autoimmunity in the Relation Between Erosions and Bone Mineral Density in Rheumatoid Arthritis
2024
Get citation
A Clinical Evaluation of the Role of Autoimmunity in the Relation Between Erosions and Bone Mineral Density in Rheumatoid Arthritis. (2024). hal.univ-lorraine.fr. https://doi.org/10.3390/biomedicines12102376

The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia -
Get citation
The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.7759/cureus.17519

Impact of immunosuppressive therapy and clinical risk factors on the prevalence of low bone mineral density in rheumatic diseases.
2026
Get citation
JM, B., M, P., T, W., K, S., V, G., & S, H. (2026). Impact of immunosuppressive therapy and clinical risk factors on the prevalence of low bone mineral density in rheumatic diseases.. doi.org. https://doi.org/10.3389/fmed.2026.1897856

Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions
2020
Get citation
Allard-Chamard, H., Carrier, N., Dufort, P., Durand, M., Brum-Fernandes, A. d., & Boire, G. (2020). Osteoclasts and their circulating precursors in rheumatoid arthritis: Relationships with disease activity and bone erosions. doi.org. https://doi.org/10.1016/j.bonr.2020.100282

Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis
2017
Get citation
Chen, Y., Chen, H., Huang, W., Liao, T., Chen, J., & Chao, W. (2017). Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. doi.org. https://doi.org/10.1371/journal.pone.0188454

Anticholinergic burden and bone health in rheumatoid arthritis.
2026
Get citation
B, U., E, S., & N, Ş. (2026). Anticholinergic burden and bone health in rheumatoid arthritis.. doi.org. https://doi.org/10.1590/1806-9282.20260191

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work